Introduction
Materials and methods
Search strategy
Inclusion criteria
Study selection
Quality assessment
Data extraction
Data synthesis and statistical methods
Results
Search results
General characteristic
Author | Country | Size (n) | Age (years) | Female (%) | Intervention | Control | Nature of study | Complications | Technique | Anesthesia | Follow-up |
---|---|---|---|---|---|---|---|---|---|---|---|
Shariat 2013 | USA | 16/16 | 61.0 | 56.2 | 30 mL 0.5% ropivacaine | Placebo | RCT | NS | Parallel | GA | NS |
Stevens 2007 | Australia | 22/22 | 54.2 | 50.0 | 40 mL mixture of 30 mL of 0.5% bupivacaine with 1:200000 epinephrine and 150 μg of clonidine | Placebo | RCT | NS | Perpendicular | SA | At discharge |
Desmet 2017 | Belgium | 43/42 | 67.5 | 65.4 | 40 mL of ropivacaine 0.5% | Placebo | RCT | NS | Perpendicular | GA | 6 months |
Bang 2016 | Korea | 11/11 | 81.6 | 85.2 | 40 mL of ropivacaine 0.2% with epinephrine 5 mg/mL | Placebo | RCT | NS | Parallel | GA | NS |
Goitia 2009 | Spanish | 21/20 | 55.6 | 55.0 | 40 ml of 5% bupivacaine | Placebo | RCT | NS | Parallel | NS | NS |
Deniz 2014 | Turkey | 20/20 | 59.1 | 56.5 | 2% prilocaine, 30 ml of 0.25% bupivacaine (1 mg/kg) | Placebo | RCT | NS | Perpendicular | GA | 3 days |
Cucereanu Badica 2010 | Romania | 30/ 32 | 71.0 | 35.4 | 50 mL of ropivacaine 0.2% with epinephrine | Placebo | RCT | NS | Perpendicular | GA | NS |
Lei 2016 | China | 23/23 | 68.7 | 45.2 | 40 ml of 5% bupivacaine | Placebo | RCT | Hematoma (n = 1) | Parallel | GA | 2 days |